AU6291098A - Novel heterocyclic compounds - Google Patents

Novel heterocyclic compounds

Info

Publication number
AU6291098A
AU6291098A AU62910/98A AU6291098A AU6291098A AU 6291098 A AU6291098 A AU 6291098A AU 62910/98 A AU62910/98 A AU 62910/98A AU 6291098 A AU6291098 A AU 6291098A AU 6291098 A AU6291098 A AU 6291098A
Authority
AU
Australia
Prior art keywords
heterocyclic compounds
novel heterocyclic
novel
compounds
heterocyclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU62910/98A
Other languages
English (en)
Inventor
Palle Jakobsen
Marit Kristiansen
Jane Marie Lundbeck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of AU6291098A publication Critical patent/AU6291098A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
AU62910/98A 1997-03-07 1998-03-06 Novel heterocyclic compounds Abandoned AU6291098A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK248/97 1997-03-07
DK24897 1997-03-07
PCT/DK1998/000084 WO1998040353A1 (en) 1997-03-07 1998-03-06 Novel heterocyclic compounds

Publications (1)

Publication Number Publication Date
AU6291098A true AU6291098A (en) 1998-09-29

Family

ID=8091404

Family Applications (1)

Application Number Title Priority Date Filing Date
AU62910/98A Abandoned AU6291098A (en) 1997-03-07 1998-03-06 Novel heterocyclic compounds

Country Status (5)

Country Link
EP (1) EP0973738A1 (ja)
JP (1) JP2001514632A (ja)
AU (1) AU6291098A (ja)
WO (1) WO1998040353A1 (ja)
ZA (1) ZA981920B (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6239163B1 (en) 1999-03-15 2001-05-29 Novo Nordisk A/S Salt of (2R,3R,4R)-3,4-dihydroxy-2-hydroxymethylpyrrolidine
US6316489B1 (en) * 1999-03-15 2001-11-13 Novo Nordisk A/S Salt of (2R,3R,4R)-3,4-dihydroxy-2-hydroxymethylpyrrolidine
CO5271699A1 (es) 2000-01-24 2003-04-30 Pfizer Prod Inc Procedimiento para el tratamiento de cardiomiopatia utilizando inhibidores de la glucogeno fosforilasa
GB0205176D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205165D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205162D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205175D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205166D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205170D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
JP2005239647A (ja) * 2004-02-27 2005-09-08 Ukima Kagaku Kenkyusho:Kk ２−置換−３，４−ジヒドロキシピロリジン酵素阻害剤
GB0614947D0 (en) * 2006-07-27 2006-09-06 Isis Innovation Epitope reduction therapy
US20150050371A1 (en) 2012-03-09 2015-02-19 Biotropics Malaysia Berhad Extract Formulations of Rhodamnia Cinerea And Uses Thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4996329A (en) * 1989-10-20 1991-02-26 Monsanto Company Derivatives of 1,4-dideoxy-1,4-imino-D-mannitol and a process for their preparation
EP0858335B1 (en) * 1995-09-08 2003-03-12 Novo Nordisk A/S 2-alkylpyrrolidines

Also Published As

Publication number Publication date
WO1998040353A1 (en) 1998-09-17
EP0973738A1 (en) 2000-01-26
ZA981920B (en) 1998-09-07
JP2001514632A (ja) 2001-09-11

Similar Documents

Publication Publication Date Title
PL338259A1 (en) Novel spiroazabicyclic heterocyclic compounds
AU1978699A (en) Heterocyclic compounds
IL132170A0 (en) Novel heterocyclic compounds
AU7210598A (en) Novel compounds
AU7907498A (en) Novel heterocyclic compounds
AUPP003197A0 (en) New heterocyclic compounds
AU6804098A (en) Triazinylaminostilbene compounds
AU5100396A (en) Novel heterocyclic compounds
AU7907298A (en) Novel heterocyclic compounds
AU6291098A (en) Novel heterocyclic compounds
AU5271096A (en) Novel heterocyclic compounds
AUPO941497A0 (en) Novel compounds
AUPO622597A0 (en) New heterocyclic compounds
AUPO527597A0 (en) Novel heterocyclic compounds
AU5270896A (en) Novel heterocyclic compounds
AU1542295A (en) Heterocyclic compounds
ZA985448B (en) Novel heterocyclic compounds
AU7041098A (en) Pi-complex compounds
AU2991397A (en) Heterocyclic compounds
PL336639A1 (en) Novel heterocyclic compounds
AU5271696A (en) Novel heterocyclic compounds
AU5271896A (en) Novel heterocyclic compounds
AU5272096A (en) Novel heterocyclic compounds
AU5271396A (en) Novel heterocyclic compounds
AU2825999A (en) Novel heterocyclic compounds